These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32880108)

  • 1. [Efficacy of new therapies].
    Ongaro M; Spahr L; Giostra E; Negro F
    Rev Med Suisse; 2020 Sep; 16(704):1538-1543. PubMed ID: 32880108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hepatitis delta: A state-of-the-art review and new therapies.
    Gilman C; Heller T; Koh C
    World J Gastroenterol; 2019 Aug; 25(32):4580-4597. PubMed ID: 31528088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of delta hepatitis.
    Gunsar F
    Expert Rev Anti Infect Ther; 2013 May; 11(5):489-98. PubMed ID: 23627855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBV/HDV Coinfection: A Challenge for Therapeutics.
    Koh C; Da BL; Glenn JS
    Clin Liver Dis; 2019 Aug; 23(3):557-572. PubMed ID: 31266627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hepatitis D: an unmet medical need.
    Caviglia GP; Rizzetto M
    Clin Microbiol Infect; 2020 Jul; 26(7):824-827. PubMed ID: 32120043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral therapy of hepatitis delta virus infection - progress and challenges towards cure.
    Wranke A; Wedemeyer H
    Curr Opin Virol; 2016 Oct; 20():112-118. PubMed ID: 27792905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of chronic hepatitis due to hepatitis B and hepatitis delta virus coinfection.
    Brancaccio G; Gaeta GB
    Int J Antimicrob Agents; 2019 Dec; 54(6):697-701. PubMed ID: 31541699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and treatment of chronic hepatitis B and D. Hungarian national consensus guideline].
    Horváth G; Hunyady B; Gervain J; Lengyel G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
    Orv Hetil; 2014 Mar; 155 Suppl():25-36. PubMed ID: 24631887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Hepatitis D.
    Rizzetto M
    Semin Liver Dis; 2018 Feb; 38(1):66-72. PubMed ID: 29471567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigational drugs in development for Hepatitis D.
    Rizzetto M
    Expert Opin Investig Drugs; 2017 Sep; 26(9):999-1005. PubMed ID: 28730878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic hepatitis B and D (delta) : Current and future treatments].
    Wortmann N; Höner Zu Siederdissen C; Cornberg M
    Internist (Berl); 2018 Jun; 59(6):519-527. PubMed ID: 29761292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic hepatitis D patients with pegylated interferon: a real-world experience.
    Abbas Z; Memon MS; Mithani H; Jafri W; Hamid S
    Antivir Ther; 2014; 19(5):463-8. PubMed ID: 24423484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Strategies and New Intervention Points in Chronic Hepatitis Delta Virus Infection.
    Guo Z; King T
    Int J Mol Sci; 2015 Aug; 16(8):19537-52. PubMed ID: 26295228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of Novel Therapies for HDV.
    Elazar M; Glenn JS
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into HDV persistence: The role of interferon response and implications for upcoming novel therapies.
    Zhang Z; Urban S
    J Hepatol; 2021 Mar; 74(3):686-699. PubMed ID: 33276031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current management of delta hepatitis.
    Rizzetto M
    Liver Int; 2013 Feb; 33 Suppl 1():195-7. PubMed ID: 23286865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy.
    Lutterkort GL; Wranke A; Hengst J; Yurdaydin C; Stift J; Bremer B; Hardtke S; Keskin O; Idilman R; Manns MP; Dienes HP; Falk C; Wedemeyer H; Heidrich B
    J Viral Hepat; 2018 Nov; 25(11):1384-1394. PubMed ID: 29888837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bulevirtide: First Approval.
    Kang C; Syed YY
    Drugs; 2020 Oct; 80(15):1601-1605. PubMed ID: 32926353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis delta virus: From biological and medical aspects to current and investigational therapeutic options.
    Alfaiate D; Dény P; Durantel D
    Antiviral Res; 2015 Oct; 122():112-29. PubMed ID: 26275800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Hepatitis D; at a Standstill?
    Rizzetto M
    Dig Dis; 2016; 34(4):303-7. PubMed ID: 27170382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.